Status:
RECRUITING
ASTHMAXcel Voice Study
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
Yeshiva University
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator te...
Detailed Description
Poor outcomes for minority patients with asthma have been linked to poverty and other social determinants of health (SDOH), environmental exposures, and poor self-management. In a previous Agency for ...
Eligibility Criteria
Inclusion
- English speaking
- Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication
- Able to provide informed consent
- Smartphone access (iOS or Android) with data plan
Exclusion
- Pregnancy
- Severe psychiatric or cognitive problems that would prohibit completion of protocol
Key Trial Info
Start Date :
September 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06935084
Start Date
September 18 2025
End Date
September 1 2028
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467